These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8453177)

  • 1. Lack of effect of influenza vaccine on anticoagulation by acenocoumarol.
    Souto JC; Oliver A; Montserrat I; Mateo J; Sureda A; Fontcuberta J
    Ann Pharmacother; 1993 Mar; 27(3):365-8. PubMed ID: 8453177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation.
    Marco F; Gutiérrez JI; Orkolaga K; Márquez JA; Ojínaga MJ; de Zárate IO; de Heredia JM
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):509-12. PubMed ID: 16905959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin.
    MacCallum P; Madhani M; Mt-Isa S; Ashby D
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):786-9. PubMed ID: 17111459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension.
    Pulido T; Sandoval J; Roquet I; Gutiérrez R; Rueda T; Peña H; Santos E; Miranda MT; Lupi E
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():14-8. PubMed ID: 19335742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
    van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
    Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study.
    Iorio A; Basileo M; Marcucci M; Guercini F; Camilloni B; Paccamiccio E; Vecchioli M; Iorio AM
    Arch Intern Med; 2010 Apr; 170(7):609-16. PubMed ID: 20386004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of influenza vaccine on warfarin anticoagulation.
    Kramer P; Tsuru M; Cook CE; McClain CJ; Holtzman JL
    Clin Pharmacol Ther; 1984 Mar; 35(3):416-8. PubMed ID: 6697649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol.
    van Schie RM; Babajeff AM; Schalekamp T; Wessels JA; le Cessie S; de Boer A; van der Meer FJ; van Meegen E; Verhoef TI; Rosendaal FR; Maitland-van der Zee AH;
    J Thromb Haemost; 2012 May; 10(5):767-72. PubMed ID: 22409277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol.
    González-Conejero R; Corral J; Roldán V; Ferrer F; Sánchez-Serrano I; Sánchez-Blanco JJ; Marín F; Vicente V
    J Thromb Haemost; 2007 Aug; 5(8):1701-6. PubMed ID: 17596133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands.
    Zhang Y; de Boer A; Verhoef TI; van der Meer FJ; Le Cessie S; Maitland-van der Zee AH; ;
    Thromb Res; 2015 Jul; 136(1):94-100. PubMed ID: 25971661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation.
    Kulo A; Kusturica J; Kapić E; Becić F; Rakanović-Todić M; Burnazović-Ristić L; Mehmedović A; Lepar O; Mulabegović N
    Med Glas (Zenica); 2011 Feb; 8(1):9-14. PubMed ID: 21263388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].
    Bernát SI; Rókusz L
    Orv Hetil; 2012 May; 153(20):786-90. PubMed ID: 22580505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study.
    Jackson ML; Nelson JC; Chen RT; Davis RL; Jackson LA;
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):790-6. PubMed ID: 17286320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miconazole oral gel enhances acenocoumarol anticoagulant activity: a report of three cases.
    Ortín M; Olalla JI; Muruzábal MJ; Peralta FG; Gutiérrez MA
    Ann Pharmacother; 1999 Feb; 33(2):175-7. PubMed ID: 10084413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon.
    Fihn SD; Gadisseur AA; Pasterkamp E; van der Meer FJ; Breukink-Engbers WG; Geven-Boere LM; van Meegen E; de Vries-Goldschmeding H; Antheunissen-Anneveld I; van't Hoff AR; Harderman D; Smink M; Rosendaal FR
    Thromb Haemost; 2003 Aug; 90(2):260-6. PubMed ID: 12888873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy.
    Kuo AM; Brown JN; Clinard V
    J Clin Pharm Ther; 2012 Oct; 37(5):505-9. PubMed ID: 22449298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled study of interaction between nabumetone and acenocoumarol.
    Pardo A; García-Losa M; Fernández-Pavón A; del Castillo S; Pascual-García T; García-Méndez E; Dal-Ré R
    Br J Clin Pharmacol; 1999 Apr; 47(4):441-4. PubMed ID: 10233210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of acenocoumarol on hemorheological parameters.
    Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement.
    Blasi A; Muñoz G; de Soto I; Mellado R; Taura P; Rios J; Balust J; Beltran J
    Thromb Res; 2015 Sep; 136(3):669-72. PubMed ID: 26232350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.
    Sunkara G; Bigler H; Wang Y; Smith H; Prasad P; McLeod J; Ligueros-Saylan M
    Curr Med Res Opin; 2004 Jan; 20(1):41-8. PubMed ID: 14741071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.